R&D Expenses

$16.87M

TTM · Period ending: Mar 31, 2022 · USD

Latest reported$16.87Mperiod endingMar 31, 2022

ATRS TTM R&D Expenses ($1.98M → $16.87M)

TTM R&D Expenses

High-resolution chart · PNG

ATRS r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Mar 31, 1997	2,584,806
Dec 31, 1996	1,984,806